These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 17907956)

  • 1. The road to LOAD: late-onset Alzheimer's disease and a possible way to block it.
    Whitfield JF
    Expert Opin Ther Targets; 2007 Oct; 11(10):1257-60. PubMed ID: 17907956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can statins put the brakes on Alzheimer's disease?
    Whitfield JF
    Expert Opin Investig Drugs; 2006 Dec; 15(12):1479-85. PubMed ID: 17107274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-density lipoprotein receptor-related protein 1: a physiological Aβ homeostatic mechanism with multiple therapeutic opportunities.
    Sagare AP; Deane R; Zlokovic BV
    Pharmacol Ther; 2012 Oct; 136(1):94-105. PubMed ID: 22820095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of HMG-CoA reductase inhibitors on beta-amyloid peptide levels: implications for Alzheimer's disease.
    Höglund K; Blennow K
    CNS Drugs; 2007; 21(6):449-62. PubMed ID: 17521225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological concentrations of the HMG-CoA reductase inhibitor lovastatin decrease the formation of the Alzheimer beta-amyloid peptide in vitro and in patients.
    Buxbaum JD; Cullen EI; Friedhoff LT
    Front Biosci; 2002 Apr; 7():a50-9. PubMed ID: 11900994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of statins on beta-amyloid metabolism in humans: potential importance for the development of senile plaques in Alzheimer's disease.
    Höglund K; Wallin A; Blennow K
    Acta Neurol Scand Suppl; 2006; 185():87-92. PubMed ID: 16866916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The conflicting role of brain cholesterol in Alzheimer's disease: lessons from the brain plasminogen system.
    Ledesma MD; Dotti CG
    Biochem Soc Symp; 2005; (72):129-38. PubMed ID: 15649137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins: drugs for Alzheimer's disease?
    Eckert GP; Wood WG; Müller WE
    J Neural Transm (Vienna); 2005 Aug; 112(8):1057-71. PubMed ID: 15682268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-assessing the relationship between cholesterol, statins and Alzheimer's disease.
    Wolozin B; Manger J; Bryant R; Cordy J; Green RC; McKee A
    Acta Neurol Scand Suppl; 2006; 185():63-70. PubMed ID: 16866913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding.
    Shackleton B; Crawford F; Bachmeier C
    Fluids Barriers CNS; 2016 Aug; 13(1):14. PubMed ID: 27503326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin-like drugs for the treatment of brain cholesterol loss in Alzheimer's disease.
    Biondi E
    Curr Drug Saf; 2007 Sep; 2(3):173-6. PubMed ID: 18690964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statin treatment and a disease-specific pattern of beta-amyloid peptides in Alzheimer's disease.
    Höglund K; Syversen S; Lewczuk P; Wallin A; Wiltfang J; Blennow K
    Exp Brain Res; 2005 Jul; 164(2):205-14. PubMed ID: 15937702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional role of lipoprotein receptors in Alzheimer's disease.
    Jaeger S; Pietrzik CU
    Curr Alzheimer Res; 2008 Feb; 5(1):15-25. PubMed ID: 18288927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astrocytic LRP1 Mediates Brain Aβ Clearance and Impacts Amyloid Deposition.
    Liu CC; Hu J; Zhao N; Wang J; Wang N; Cirrito JR; Kanekiyo T; Holtzman DM; Bu G
    J Neurosci; 2017 Apr; 37(15):4023-4031. PubMed ID: 28275161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesterol and Alzheimer's disease: statins, cholesterol depletion in APP processing and Abeta generation.
    Hartman T
    Subcell Biochem; 2005; 38():365-80. PubMed ID: 15709489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cellular biochemistry of cholesterol and statins: insights into the pathophysiology and therapy of Alzheimer's disease.
    Wolozin B; Brown J; Theisler C; Silberman S
    CNS Drug Rev; 2004; 10(2):127-46. PubMed ID: 15179443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cholesterol and Alzheimer's disease].
    Kálmán J; Janka Z
    Orv Hetil; 2005 Sep; 146(37):1903-11. PubMed ID: 16255374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's disease: progress in the development of anti-amyloid disease-modifying therapies.
    Christensen DD
    CNS Spectr; 2007 Feb; 12(2):113-6, 119-23. PubMed ID: 17277711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins: the role in the treatment and prevention of Alzheimer's neurodegeneration.
    Pac-Soo C; Lloyd DG; Vizcaychipi MP; Ma D
    J Alzheimers Dis; 2011; 27(1):1-10. PubMed ID: 21734347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Vitamin D in Amyloid clearance via LRP-1 upregulation in Alzheimer's disease: A potential therapeutic target?
    Patel P; Shah J
    J Chem Neuroanat; 2017 Nov; 85():36-42. PubMed ID: 28669880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.